A machine learning PET/CT model shows promise for predicting radiation dose prior to Lu-177 PSMA therapy in prostate cancer patients.
Key Details
- 1Study presented at SNMMI evaluated a machine learning model using F-18 PSMA PET/CT imaging.
- 2Nine patients with metastatic castration-resistant prostate cancer were included, analyzing a total of 57 tumors, 36 salivary glands, and 18 kidneys.
- 3The model used uptake-based PET metrics, radiomic features, and clinical biomarkers for dose prediction.
- 4Predictions closely tracked absorbed dose values obtained from traditional post-therapy dosimetry.
- 5Using pre-therapy PET/CT data could eliminate need for additional scans and reduce patient burden.
- 6The approach is part of a larger, ongoing 5-year research program for validation.
Why It Matters
This approach suggests standard diagnostic imaging can be repurposed with AI to deliver patient-specific radiation dose estimates before therapy, potentially improving safety, efficacy, and workflow efficiency in radiopharmaceutical therapy.
Source
AuntMinnie
Related News
•Radiology Business
Meta Funds Ohio State’s Radiology AI Innovation Projects
Meta will fund Ohio State researchers to explore AI-driven advancements in radiology, including chest X-ray reporting and disease prediction.
•AuntMinnie
ChatGPT-5 Performs Poorly at Detecting Distal Radius Fractures on X-rays
ChatGPT-5 missed about half of distal radius fractures on x-rays, showing limited diagnostic capability in a real-world scenario.
•AuntMinnie
AI Triage Tool Speeds Up ICH Head CT Turnaround in ED
AI-based triage for intracranial hemorrhage on head CT reduced emergency department report turnaround by 13 minutes.